Elastrin Therapeutics, Inc.
Biotechnology company · Greenville, South Carolina, United States
Elastrin Therapeutics, Inc. is a biotechnology company headquartered in Greenville, South Carolina, United States. Its earliest recorded incorporation is in 2017. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $283,980 in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $500,000 sold in a notice filed in 2025.
Elastrin Therapeutics at a glance
What does Elastrin Therapeutics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $283,980 in total (2019). NIH funding came from the National Heart, Lung, and Blood Institute.
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $500,000 sold (2025).
Frequently asked questions about Elastrin Therapeutics
Where is Elastrin Therapeutics headquartered?
Elastrin Therapeutics, Inc. is headquartered in Greenville, South Carolina, United States.
What does Elastrin Therapeutics do?
Elastrin Therapeutics, Inc. is a biotechnology company.
When was Elastrin Therapeutics founded?
The earliest incorporation on record for Elastrin Therapeutics, Inc. is in 2017, according to public company registers.
Similar companies
- Kiyatec Inc.Greenville, South Carolina, United States
- Purilogics, LLCGreenville, South Carolina, United States
- Techshot, Inc.Greenville, Indiana, United States
- Respire LLCGreenville, Delaware, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences